1. Home
  2. NVTS vs HROW Comparison

NVTS vs HROW Comparison

Compare NVTS & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVTS
  • HROW
  • Stock Information
  • Founded
  • NVTS 2014
  • HROW 1998
  • Country
  • NVTS United States
  • HROW United States
  • Employees
  • NVTS N/A
  • HROW N/A
  • Industry
  • NVTS Semiconductors
  • HROW Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVTS Technology
  • HROW Health Care
  • Exchange
  • NVTS Nasdaq
  • HROW Nasdaq
  • Market Cap
  • NVTS 1.3B
  • HROW 1.1B
  • IPO Year
  • NVTS N/A
  • HROW N/A
  • Fundamental
  • Price
  • NVTS $6.64
  • HROW $32.81
  • Analyst Decision
  • NVTS Buy
  • HROW Strong Buy
  • Analyst Count
  • NVTS 7
  • HROW 7
  • Target Price
  • NVTS $4.93
  • HROW $61.83
  • AVG Volume (30 Days)
  • NVTS 31.7M
  • HROW 463.6K
  • Earning Date
  • NVTS 08-04-2025
  • HROW 08-11-2025
  • Dividend Yield
  • NVTS N/A
  • HROW N/A
  • EPS Growth
  • NVTS N/A
  • HROW N/A
  • EPS
  • NVTS N/A
  • HROW N/A
  • Revenue
  • NVTS $74,145,000.00
  • HROW $212,858,000.00
  • Revenue This Year
  • NVTS N/A
  • HROW $46.17
  • Revenue Next Year
  • NVTS $51.14
  • HROW $39.97
  • P/E Ratio
  • NVTS N/A
  • HROW N/A
  • Revenue Growth
  • NVTS N/A
  • HROW 53.49
  • 52 Week Low
  • NVTS $1.52
  • HROW $20.85
  • 52 Week High
  • NVTS $9.48
  • HROW $59.23
  • Technical
  • Relative Strength Index (RSI)
  • NVTS 43.66
  • HROW 47.23
  • Support Level
  • NVTS $6.24
  • HROW $30.12
  • Resistance Level
  • NVTS $8.28
  • HROW $33.90
  • Average True Range (ATR)
  • NVTS 0.87
  • HROW 1.70
  • MACD
  • NVTS -0.19
  • HROW -0.52
  • Stochastic Oscillator
  • NVTS 8.23
  • HROW 31.87

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: